Cytokine Combinations Increase p75 Tumor Necrosis Factor Receptor Binding and Stimulate Receptor Shedding in Rheumatoid Synovial Fibroblasts
Open Access
- 1 February 1994
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 37 (2) , 232-235
- https://doi.org/10.1002/art.1780370212
Abstract
Objective. To identify cytokines responsible for the increased levels of tumor necrosis factor receptor (TNFR) in the joints of patients with rheumatoid arthritis. Methods. Antibodies to TNFR types were used both to inhibit ligand cell binding and to quantify released receptors in rheumatoid synovial fibroblasts. Results. Binding by and shedding of the p75 TNFR was affected by interleukin-1 (IL-1), IL-4, and interferon-γ. Conclusion. IL-1 could cause increased TNFα binding and TNFR shedding in inflamed joints.Keywords
This publication has 11 references indexed in Scilit:
- Studies on the expression of the TNF? receptors (p55 and p75) and their relative contributions to prostanoid production and glycolytic rate by rheumatoid synovial fibroblasts in vitroRheumatology International, 1993
- Two TNF receptorsImmunology Today, 1992
- Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin‐4 in an ex vivo model of rheumatoid synovitisArthritis & Rheumatism, 1992
- TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?Rheumatology, 1992
- High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia.Journal of Clinical Investigation, 1992
- Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritisJournal of Molecular Medicine, 1992
- Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils.Journal of Biological Chemistry, 1991
- Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.Proceedings of the National Academy of Sciences, 1990